EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
|
EQS-Ad-hoc: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Strategic corporate decision/Other Asklepios Kliniken GmbH & Co. KGaA with registered office in Hamburg today submitted the request to the management board of RHÖN-Klinikum Aktiengesellschaft that the general meeting of RHÖN-Klinikum Aktiengesellschaft resolves upon the transfer of the shares of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft to Asklepios Kliniken GmbH & Co. KGaA against payment of an adequate cash compensation (so-called squeeze-out). Asklepios Kliniken GmbH & Co. KGaA holds (indirectly) more than 95 percent of the shares in RHÖN-Klinikum Aktiengesellschaft and is therefore the main shareholder within the meaning of section 327a German Stock Corporation Act (Aktiengesetz – AktG).
Asklepios Kliniken GmbH & Co. KGaA will determine the amount of the cash compensation on the basis of a company valuation. The adequacy of the cash compensation will be reviewed by a court appointed expert auditor. The squeeze-out will become effective upon the adoption of the corresponding resolution by the general meeting of RHÖN-Klinikum Aktiengesellschaft and its registration in the commercial register of the company with the local court (Amtsgericht) Schweinfurt. The resolution on the squeeze-out is expected to take place at an extraordinary general meeting in January 2027. Contact: Norman Dittes Head of Group Finance RHÖN-KLINIKUM AG Group Finance Schlossplatz 1 • 97616 Bad Neustadt a. d. Saale Tel.: +49 9771 65-12210 End of Inside Information
07-Aug-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | RHÖN-KLINIKUM Aktiengesellschaft |
| Salzburger Leite 1 | |
| 97616 Bad Neustadt a. d. Saale | |
| Germany | |
| Phone: | +49 (0)9771 - 65-0 |
| Fax: | +49 (0)9771 - 97 467 |
| E-mail: | rka@rhoen-klinikum-ag.com |
| Internet: | www.rhoen-klinikum-ag.com |
| ISIN: | DE0007042301 |
| WKN: | 704230 |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate BSX |
| LEI Code: | 529900MVGMIVUDQY9E20 |
| EQS News ID: | 2379290 |
| End of Announcement | EQS News Service |
|
|
2379290 07-Aug-2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 1.360,16 | 1.402,01 | 1.446,09 | 1.463,98 | 1.595,62 | 1.704,72 | 1.700,00 | |
| EBITDA1,2 | 80,23 | 101,16 | 105,65 | 105,88 | 110,77 | 105,94 | 117,00 | |
| EBITDA-Margin3 | 5,90 | 7,22 | 7,31 | 7,23 | 6,94 | 6,22 | 6,88 | |
| EBIT1,4 | 10,60 | 30,52 | 36,11 | 40,40 | 48,15 | 40,94 | 44,00 | |
| EBIT-Margin5 | 0,78 | 2,18 | 2,50 | 2,76 | 3,02 | 2,40 | 2,59 | |
| Net Profit (Loss)1 | 2,46 | 30,23 | 26,94 | 40,17 | 45,21 | 36,28 | 40,00 | |
| Net-Margin6 | 0,18 | 2,16 | 1,86 | 2,74 | 2,83 | 2,13 | 2,35 | |
| Cashflow1,7 | 113,30 | 97,50 | 41,30 | 109,00 | 127,60 | 57,20 | 85,00 | |
| Earnings per share8 | 0,02 | 0,42 | 0,38 | 0,58 | 0,65 | 0,52 | 0,60 | |
| Dividend per share8 | 0,00 | 0,00 | 0,15 | 0,00 | 0,10 | 0,20 | 0,20 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: KPMG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Rhön-Klinikum | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 704230 | DE0007042301 | AG | 964,26 Mio € | 19.06.1991 | Halten | 9F2G86FM+GX |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 21,82 | 27,33 | 0,80 | 28,35 | -0,54 | 16,86 | 0,57 |
|
Dividend '2024 in € |
Dividend '2025 in € |
Dividend '2026e in € |
Div.-Yield '2026e in % |
| 0,10 | 0,20 | 0,20 | 1,39% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 27.05.2026 | 07.05.2026 | 06.08.2026 | 05.11.2026 | 26.03.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +4,02% | +10,43% | +13,39% | +24,14% | +476,00% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
